Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-23T19:29:26.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Combination of clozapine and maprotiline in refractory psychotic depression

Published online by Cambridge University Press:  16 April 2020

M. Hrdlička
M. Hrdlička*
Affiliation:
Department of Psychiatry, Charles University, Second Medical School, V uvalu 84, 15006, Prague, Czech Republic
*
*Corresponding author. E-mail addressMichal.Hrdlicka@lfmotol.cuni.cz (M. Hrdlička).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case Report
Information
European Psychiatry , Volume 17 , Issue 8 , December 2002 , pp. 484
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chong, S.A., Remington, G.Clozapine augmentation: safety and effficacy Schizophr Bull 2000; 26: 421-440.Google Scholar
Wahlbeck, K., Cheine, M., Essali, A., Adams, C.Evidence of clozapineˈs effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials Am J Psychiatry 1999; 156: 990-999.Google Scholar
Wheeler, J.A., Mortimer, A.M., Tyson, P.J.Somatic treatment of psychotic depression: review and recommendations for practice J Clin Psychopharmacol 2000; 20: 504-519.Google Scholar
Submit a response

Comments

No Comments have been published for this article.